SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00010



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_PF1_Subject_04 1 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_RT_Subject_10 1 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_01 3 Human HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_02 3 Human HLA-A03_01,HLA-A29_02,HLA-B08_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_03 15 Human HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_04 19 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_05 7 Human HLA-A03_01,HLA-A11_01,HLA-B44_03,HLA-B50_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_06 6 Human HLA-A02_01,HLA-A11_01,HLA-B40_01,HLA-B44_03,HLA-C03_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_07 9 Human HLA-A02_01,HLA-A23_01,HLA-B18_01,HLA-B44_03,HLA-C04_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_08 20 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_09 20 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_10 19 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 20 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_12 3 Human HLA-A02_01,HLA-B13_02,HLA-B41_01,HLA-C06_02,HLA-C17_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_13 3 Human HLA-A02_01,HLA-A11_01,HLA-B27_05,HLA-B56_01,HLA-C01_02,HLA-C02_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_14 4 Human HLA-A03_01,HLA-A32_01,HLA-B27_05,HLA-B45_01,HLA-C01_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_15 9 Human HLA-A01_01,HLA-A32_01,HLA-B08_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_16 3 Human HLA-A11_01,HLA-B14_02,HLA-B44_02,HLA-C05_01,HLA-C08_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_17 3 Human HLA-A11_01,HLA-B18_03,HLA-B35_01,HLA-C04_01,HLA-C07_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_18 3 Human HLA-A03_01,HLA-A24_02,HLA-B07_02,HLA-B27_05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_CELG_Subject_11 3 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_C_Subject_08 3 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_J_Subject_09 6 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_MA_Subject_03 3 Human HLA-A02_01,HLA-A29_02,HLA-B57_01,HLA-B44_03,HLA-C07_01,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_PF1_Subject_04 3 Human HLA-A02_01,HLA-A01_01,HLA-B07_02,HLA-B44_03,HLA-C07_02,HLA-C16_01
SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_pat_RT_Subject_10 3 Human HLA-A02_01,HLA-A01_01,HLA-B18_01,HLA-B39_24,HLA-C05_01,HLA-C07_01



Detailed view of sample SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep6_021213_Fx600mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 1
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep3_021213_Fx50mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 2
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep3_021213_Fx600mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 3
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep3_021213_Fx75mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 4
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep4_021213_Fx100mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 5
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep4_021213_Fx300mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 6
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep4_021213_Fx50mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 7
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep4_021213_Fx600mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 8
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep3_021213_Fx300mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 9
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep4_021213_Fx75mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 10
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep5_021213_Fx300mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 11
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep5_021213_Fx50mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 12
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep5_021213_Fx600mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 13
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep5_021213_Fx75mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 14
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep6_021213_Fx100mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 15
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep6_021213_Fx300mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 16
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep6_021213_Fx50mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 17
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep5_021213_Fx100mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 18
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep3_021213_Fx100mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 19
SYSMHC00010 SYSMHC00010_gradosd_160630_perreault-thibault_cada_LCL_Subject_11 SYSMHC00010_CELG_rep6_021213_Fx75mM.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B73_01,HLA-C03_03,HLA-C15_05 26857467 native Mild acid elution Orbitrap Elite no DDA CID 5-40% 56 20